Arthur Swislocki

Title(s)Professor of Clinical, MED: Int Med Endocrinology
SchoolSchool of Medicine
AddressG400 PSSB/UCDMC
CA 95817
Phone916-734-3730
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Review on Testosterone: Estradiol Ratio-Does It Matter, How Do You Measure It, and Can You Optimize It? World J Mens Health. 2024 Aug 30. Swislocki ALM, Eisenberg ML. PMID: 39344113.
      View in: PubMed   Mentions:
    2. Uric Acid: Is It Time to Come in From the Cold? Metab Syndr Relat Disord. 2022 09; 20(7):367-369. Swislocki ALM. PMID: 35612466.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Retained Glucose Sensor Wire as a Cause of Leg Pain. Clin Diabetes. 2022; 40(2):247-249. Swislocki ALM, Krouwer J, Ravera JJ. PMID: 35669306; PMCID: PMC9160552.
      View in: PubMed   Mentions: 1  
    4. Glucose Trajectory: More than Changing Glucose Tolerance with Age? Metab Syndr Relat Disord. 2022 08; 20(6):313-320. Swislocki ALM. PMID: 35426740.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Peyronie Disease as a Marker of Inflammation-Is There Hope on the Horizon? Am J Med. 2021 10; 134(10):1218-1223. Swislocki ALM, Eisenberg ML. PMID: 34273285.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Fatty Pancreas: An Underappreciated Intersection of the Metabolic Profile and Pancreatic Adenocarcinoma. Metab Syndr Relat Disord. 2021 08; 19(6):317-324. Swislocki A. PMID: 33656378.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Assessing the Continuation of Glucagon-Like Peptide-1 Receptor Agonists When Weight and HBA1C Are Not Reduced. Metab Syndr Relat Disord. 2020 09; 18(7):321-327. Zhou R, Duncan K, Lopez J, Rich K, Swislocki A. PMID: 32580677.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. The Lived Experience of Older Adults With Type 2 Diabetes Mellitus and Diabetes-Related Distress. J Gerontol Nurs. 2020 Mar 01; 46(3):37-44. Hernandez L, Leutwyler H, Cataldo J, Kanaya A, Swislocki A, Chesla C. PMID: 32083700.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Symptom Experience of Older Adults With Type 2 Diabetes and Diabetes-Related Distress. Nurs Res. 2019 Sep/Oct; 68(5):374-382. Hernandez L, Leutwyler H, Cataldo J, Kanaya A, Swislocki A, Chesla C. PMID: 31465305; PMCID: PMC6716610.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Nonglycemic Effects of GLP-1 Agonists: From a Starling to Lizards to People. Metab Syndr Relat Disord. 2019 Jul/Aug; 17(6):303-313. Sood A, Swislocki A. PMID: 31145029.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    11. The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Metab Syndr Relat Disord. 2019 05; 17(4):192-196. Villegas K, Meier JL, Long M, Lopez J, Swislocki A. PMID: 30730235.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    12. Adherence to and Persistence With Statin Therapy in a Veteran Population. Ann Pharmacother. 2019 01; 53(1):43-49. Morotti K, Lopez J, Vaupel V, Swislocki A, Siegel D. PMID: 30084646.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Prevalence of Suspicious Ultrasound Features in Hot Thyroid Nodules. Fed Pract. 2018 May; 35(Suppl 4):S46-S48. Chang DJ, Lippman SS, Semrad AM, Volpp B, Swislocki ALM. PMID: 30766400; PMCID: PMC6375418.
      View in: PubMed   Mentions:
    14. A Perspective on Reagent Diversity and Non-covalent Binding of Reactive Carbonyl Species (RCS) and Effector Reagents in Non-enzymatic Glycation (NEG): Mechanistic Considerations and Implications for Future Research. Front Chem. 2017; 5:39. Rodnick KJ, Holman RW, Ropski PS, Huang M, Swislocki ALM. PMID: 28713809; PMCID: PMC5491550.
      View in: PubMed   Mentions: 3  
    15. Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study. Metab Syndr Relat Disord. 2016 10; 14(8):375-377. Swislocki AL, Jialal I. PMID: 27552667.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest? Metab Syndr Relat Disord. 2016 Feb; 14(1):3-6. Swislocki AL, Jialal I. PMID: 26677930.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients. Ann Pharmacother. 2015 Sep; 49(9):969-77. Aterrado S, Ono G, Kanehira-Mar S, Meier J, Swislocki A. PMID: 26104054.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors. Metab Syndr Relat Disord. 2015 Sep; 13(7):287-91. Swislocki AL, Jialal I. PMID: 25893855.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    19. Comparing fracture absolute risk assessment (FARA) tools: an osteoporosis clinical informatics tool to improve identification and care of men at high risk of first fracture. Ann Pharmacother. 2015 May; 49(5):506-14. LaFleur J, Steenhoek CL, Horne J, Meier J, Nebeker JR, Mambourg S, Swislocki A, Carmichael J. PMID: 25712443.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Hypothalamic-Pituitary-Adrenal Suppression and Iatrogenic Cushing's Syndrome as a Complication of Epidural Steroid Injections. Case Rep Endocrinol. 2013; 2013:617042. Leary J, Swislocki A. PMID: 23991341; PMCID: PMC3749537.
      View in: PubMed   Mentions: 4  
    21. HbA1c and metabolic syndrome. Metab Syndr Relat Disord. 2012 Dec; 10(6):391-3. Swislocki A. PMID: 23025691.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Pharmacotherapy for the metabolic syndrome. Curr Vasc Pharmacol. 2012 Mar; 10(2):187-205. Swislocki AL, Siegel D, Jialal I. PMID: 22022773.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    23. Plasma testosterone is associated with Framingham risk score. Aging Male. 2012 Sep; 15(3):134-9. Chock B, Lin TC, Li CS, Swislocki A. PMID: 22364636.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men. Metab Syndr Relat Disord. 2012 Feb; 10(1):32-8. Kelley DS, Adkins Y, Woodhouse LR, Swislocki A, Mackey BE, Siegel D. PMID: 21999398.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. Long-term maintenance of glucose control in veterans with type 2 diabetes mellitus using oral agents. Metab Syndr Relat Disord. 2011 Dec; 9(6):469-73. Swislocki AL, Meier JL, Najera SM, Noth RH. PMID: 21864034.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):487-91. Garcia EA, Lopez JR, Meier JL, Swislocki AL, Siegel D. PMID: 21762361; PMCID: PMC8108800.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. The ACCORD Study: the devil is in the details. Metab Syndr Relat Disord. 2011 Apr; 9(2):81-4. Siegel D, Swislocki AL. PMID: 21166575.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    28. Prevalence of osteoporosis in men in a VA rehabilitation center. Am J Manag Care. 2010 Jun; 16(6):427-33. Swislocki A, Green JA, Heinrich G, Barnett CA, Meadows ID, Harmon EB, Rank MF, Noth RH. PMID: 20560686.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    29. Hypertensive treatment in patients with metabolic syndrome. Metab Syndr Relat Disord. 2010 Apr; 8(2):95-104. Siegel D, Swislocki AL. PMID: 20156078.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. The effect of body mass index on fasting blood glucose and development of diabetes mellitus after initiation of extended-release niacin. Metab Syndr Relat Disord. 2010 Feb; 8(1):79-84. Libby A, Meier J, Lopez J, Swislocki AL, Siegel D. PMID: 19943800.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Computer-based screening of veterans for metabolic syndrome. Metab Syndr Relat Disord. 2009 Dec; 7(6):557-61. Keane J, Meier JL, Noth RH, Swislocki AL. PMID: 19558266.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    32. A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage. 2010 Jan; 39(1):88-99. Swislocki A, Orth M, Bales M, Weisshaupt J, West C, Edrington J, Cooper B, Saputo L, Islas M, Miaskowski C. PMID: 19896325.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Computer confirmation of improved blood pressure control in diabetic patients. Prev Cardiol. 2009; 12(3):149-54. Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. PMID: 19523058.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats. Metab Syndr Relat Disord. 2008 Dec; 6(4):257-62. Swislocki AL, Fakiri Z. PMID: 19067528.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    35. Computer-based screening of chest X-rays for vertebral compression fractures as an osteoporosis index in men. Bone. 2008 Jun; 42(6):1214-8. Nakai Y, Noth R, Wexler J, Volpp B, Tsodikov A, Swislocki A. PMID: 18395504.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    36. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. Am J Hypertens. 2008 Apr; 21(4):438-42. Siegel D, Meier J, Maas C, Lopez J, Swislocki AL. PMID: 18246056.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Acarbose attenuates Basal and postprandial insulin concentrations but fails to lower blood pressure in the spontaneously hypertensive rat. Metab Syndr Relat Disord. 2007 Dec; 5(4):297-304. Swislocki A, Lardinois CK, Starich GH. PMID: 18370799.
      View in: PubMed   Mentions: 1     Fields:    
    38. Effects of antihypertensives on glucose metabolism. Metab Syndr Relat Disord. 2007 Sep; 5(3):211-9. Siegel D, Swislocki AL. PMID: 18370775.
      View in: PubMed   Mentions: 8     Fields:    
    39. Adoption of a new technology in a Veterans Affairs national formulary system with local implementation: the insulin glargine example. Manag Care Interface. 2007 Mar; 20(3):37-44, 57. Barengolts EI, Burke BV, Duckworth WC, Kaminsky R, Miller DR, Swislocki AL. PMID: 17458480.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. The stumble-from pipe cleaner to bone builder. Endocr Pract. 2007 Mar-Apr; 13(2):194-7. Swislocki AL, Wexler JA. PMID: 17490936.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    41. Blood pressure control in a diabetic population assessed by computer review. J Hum Hypertens. 2006 Jul; 20(7):540-2. Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. PMID: 16543913.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Secretin-stimulated amylase release into blood is impaired in type 1 diabetes mellitus. Horm Metab Res. 2005 May; 37(5):326-30. Swislocki A, Noth R, Hallstone A, Kyger E, Triadafilopoulos G. PMID: 15971157.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    43. Smokeless nicotine administration does not result in hypertension or a deterioration in glucose tolerance or insulin sensitivity in juvenile rats. Metabolism. 2003 Jan; 52(1):67-72. Swislocki AL. PMID: 12524664.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    44. Effects of ovariectomy on indices of insulin resistance, hypertension, and cardiac energy metabolism in middle-aged spontaneously hypertensive rats (SHR). Horm Metab Res. 2002 Sep; 34(9):516-22. Swislocki A, Burgie ES, Rodnick KJ. PMID: 12384829.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    45. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. Am J Manag Care. 2002 Jun; 8(6):557-65. Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D. PMID: 12068962.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    46. Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats. Am J Hypertens. 2001 Jul; 14(7 Pt 1):708-15. LaPier TL, Swislocki AL, Clark RJ, Rodnick KJ. PMID: 11465658.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    47. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes. Am J Manag Care. 2001 Mar; 7(3):283-95. Swislocki AL, Siegel D. PMID: 11258145.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat. Am J Hypertens. 2000 Apr; 13(4 Pt 1):370-5. Grinsell JW, Lardinois CK, Swislocki A, Gonzalez R, Sare JS, Michaels JR, Starich GH. PMID: 10821338.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    49. Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats. Am J Hypertens. 1999 Jun; 12(6):581-9. Swislocki AL, LaPier TL, Khuu DT, Fann KY, Tait M, Rodnick KJ. PMID: 10371367.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    50. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1999 Feb 03; 281(5):417-9. Siegel D, Swislocki AL. PMID: 9952198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1999 Feb 03; 281(5):414; author reply 417-9. Haq IU, Wallis EJ, Yeo WW, Jackson PR, Ramsay LE. PMID: 9952191.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Safety and efficacy of metformin in a restricted formulary. Am J Manag Care. 1999 Jan; 5(1):62-8. Swislocki AL, Khuu Q, Liao E, Wu E, Beza F, Lopez J, Kwan G, Noth RH. PMID: 10345968.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Hyperthyroidism: an underappreciated cause of diffuse bone disease. Clin Nucl Med. 1998 Apr; 23(4):241-3. Swislocki AL, Barnett CA, Darnell P, Noth RH. PMID: 9554201.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Case report. Pseudohepatotoxicity of metformin. Diabetes Care. 1998 Apr; 21(4):677-8. Swislocki AL, Noth R. PMID: 9571371.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Insulin resistance and hypertension: in vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens. 1997 Oct; 10(10 Pt 1):1159-64. Swislocki AL, Goodman MN, Khuu DT, Fann KY. PMID: 9370388.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    56. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study. Am J Manag Care. 1997 Oct; 3(10):1537-45. Swislocki AL, Lin K, Cogburn D, Fann KY, Khuu DT, Noth RH. PMID: 10178460.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Smokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats. Metabolism. 1997 Sep; 46(9):1008-12. Swislocki AL, Tsuzuki A, Tait M, Khuu D, Fann K. PMID: 9284888.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    58. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats. Am J Hypertens. 1995 Oct; 8(10 Pt 1):1009-14. Swislocki A, Eason T, Kaysen GA. PMID: 8845069.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    59. Glucose tolerance and blood pressure are improved in the spontaneously hypertensive rat by ethyl-2-(6-(4-chlorophenoxy)-hexyl)oxirane-2-carboxylate (etomoxir), an inhibitor of fatty acid oxidation. Am J Hypertens. 1994 Aug; 7(8):739-44. Swislocki A, Eason T. PMID: 7986465.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    60. Impaired insulin clearance in essential hypertension. J Hum Hypertens. 1994 Mar; 8(3):185-90. Swislocki AL. PMID: 7911838.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean spontaneously hypertensive rat. Am J Med Sci. 1993 Nov; 306(5):282-6. Swislocki A, Tsuzuki A. PMID: 8238081.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    62. Microalbuminuria in a normotensive insulin-treated diabetic population. Horm Metab Res. 1993 Oct; 25(10):532-5. Swislocki A, Noth R, Kaplan R, Dowdell L, Lamothe J, Claire D, Smith C, Fishman I, Onufer C. PMID: 8262462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia. J Clin Endocrinol Metab. 1993 Aug; 77(2):494-7. Caticha O, Odell WD, Wilson DE, Dowdell LA, Noth RH, Swislocki AL, Lamothe JJ, Barrow R. PMID: 8345057.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    64. Acute metabolic effects of clonidine and adenosine in man. Horm Metab Res. 1993 Feb; 25(2):90-5. Swislocki AL, Vestal RE, Reaven GM, Hoffman BB. PMID: 8458615.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Insulin syringe disposal patterns at a VA hospital. Diabetes Care. 1991 Oct; 14(10):930-2. Swislocki A, Cram D, Noth R, Dowdell L, Lamothe J, Ogi G. PMID: 1773698.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    66. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens. 1991 Mar; 4(3 Pt 1):199-205. Sheu WH, Swislocki AL, Hoffman B, Chen YD, Reaven GM. PMID: 2043298.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    67. High density lipoprotein turnover in patients with hypertension. Hypertension. 1991 Mar; 17(3):386-93. Chen YD, Sheu WH, Swislocki AL, Reaven GM. PMID: 1900259.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Correction. West J Med. 1991 Mar; 154(3):353. Swislocki AL, Camargo CA, Hoffman AR. PMID: 18750807; PMCID: PMC1002779.
      View in: PubMed   Mentions:    Fields:    
    69. Workshop III--Insulin resistance: is it truly the link? Am J Med. 1991 Feb 21; 90(2A):26S-31S. Izzo JL, Swislocki AL. PMID: 1994712.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    70. McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism. West J Med. 1990 Dec; 153(6):653-6. Swislocki AL, Camargo CA, Hoffman AR. PMID: 2293479; PMCID: PMC1002653.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. Effect of prazosin treatment on HDL kinetics in patients with hypertension. Am J Hypertens. 1990 Oct; 3(10):761-8. Sheu WH, Swislocki AL, Hoffman BB, Reaven GM, Chen YD. PMID: 2121164.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. California living II: not-the-big-one had no effect on blood pressure. JAMA. 1990 Sep 19; 264(11):1411. Swislocki A, Dowdell L, Noth R. PMID: 2391737.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Insulin resistance and hypertension. Am J Med Sci. 1990 Aug; 300(2):104-15. Swislocki A. PMID: 2206054.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    74. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989 Jun; 2(6 Pt 1):419-23. Swislocki AL, Hoffman BB, Reaven GM. PMID: 2667570.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    75. Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care. 1989 Feb; 12(2):94-101. Coulston AM, Hollenbeck CB, Swislocki AL, Reaven GM. PMID: 2539286.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    76. Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension. Am J Med. 1989 Jan 23; 86(1B):14-8. Swislocki AL, Hoffman BB, Sheu WH, Chen YD, Reaven GM. PMID: 2643861.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest. 1989 Jan; 83(1):108-12. Eichler HG, Ford GA, Blaschke TF, Swislocki A, Hoffman BB. PMID: 2562959; PMCID: PMC303650.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    78. Effect of time on measurement of hepatic glucose production. J Clin Endocrinol Metab. 1988 Nov; 67(5):1084-8. Chen YD, Swislocki AL, Jeng CY, Juang JH, Reaven GM. PMID: 3182959.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    79. Effect of enprostil on plasma glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Horm Metab Res. 1988 Oct; 20(10):633-6. Reaven GM, Swislocki AL, Jeng CY, Hollenbeck CB, Schwartz K, Chen YD. PMID: 3146538.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects. Am J Physiol. 1987 Nov; 253(5 Pt 1):E489-95. Rodnick KJ, Haskell WL, Swislocki AL, Foley JE, Reaven GM. PMID: 3318492.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    81. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 1987 Aug; 30(8):622-6. Swislocki AL, Chen YD, Golay A, Chang MO, Reaven GM. PMID: 3308603.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    82. Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects with NIDDM. Diabetes Care. 1987 Jul-Aug; 10(4):395-400. Coulston AM, Hollenbeck CB, Swislocki AL, Reaven GM. PMID: 3304893.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    83. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism. 1987 Jul; 36(7):692-6. Golay A, Swislocki AL, Chen YD, Reaven GM. PMID: 3298937.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    84. Can insulin resistance exist as a primary defect in noninsulin-dependent diabetes mellitus? J Clin Endocrinol Metab. 1987 Apr; 64(4):778-82. Swislocki AL, Donner CC, Fraze E, Chen YD, Reaven GM. PMID: 3546354.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    85. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med. 1987 Feb; 82(2):213-20. Coulston AM, Hollenbeck CB, Swislocki AL, Chen YD, Reaven GM. PMID: 3544839.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    86. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1987 Jan; 64(1):17-21. Chen YD, Golay A, Swislocki AL, Reaven GM. PMID: 3782431.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    87. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1987 Jan; 64(1):106-10. Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. PMID: 3536980.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    88. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab. 1986 Aug; 63(2):481-4. Golay A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM. PMID: 3522620.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    89. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1985 Nov; 61(5):807-11. Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. PMID: 3900120.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    Arthur's Networks
    Concepts (330)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California